What is Spinogenix worth?
$335.0Mlast known valuation
Spinogenix last raised $10.6M in its Early Stage VC (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 7 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Spinogenix
Create free account
No card required
Funding history
7 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Early Stage VC | $10.6M | ▮ | ▮ |
| Jun 2024 | Seed Round | $2.8M | ▮ | ▮ |
| Jul 2023 | Early Stage VC | $5.2M | ▮ | ▮ |
| Sep 2022 | Seed Round | $3.3M | ▮ | ▮ |
| Feb 2021 | Seed Round | $1.6M | ▮ | ▮ |
| Aug 2019 | Seed Round | $250K | ▮ | ▮ |
| + 1 earlier rounds · a free account shows the full history | ||||
How Spinogenix's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Spinogenix, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Spinogenix worth?
- Spinogenix's last known valuation is $335.0M.
- How much has Spinogenix raised?
- Spinogenix has raised $27.4M in total funding across 7 recorded rounds.
- When did Spinogenix last raise?
- Spinogenix last raised in Nov 2025 (Early Stage VC), raising $10.6M.